KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Clorox (CLX) Research & Development (2016 - 2026)

Clorox has reported Research & Development over the past 18 years, most recently at $27.0 million for Q1 2026.

  • For Q1 2026, Research & Development changed 0.0% year-over-year to $27.0 million; the TTM value through Mar 2026 reached $116.0 million, down 4.92%, while the annual FY2025 figure was $121.0 million, 3.97% down from the prior year.
  • Research & Development for Q1 2026 was $27.0 million at Clorox, down from $29.0 million in the prior quarter.
  • Over five years, Research & Development peaked at $38.0 million in Q2 2023 and troughed at $27.0 million in Q1 2025.
  • A 5-year average of $31.4 million and a median of $32.0 million in 2022 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: decreased 24.44% in 2022 and later rose 12.9% in 2023.
  • Year by year, Research & Development stood at $33.0 million in 2022, then fell by 3.03% to $32.0 million in 2023, then fell by 3.12% to $31.0 million in 2024, then dropped by 6.45% to $29.0 million in 2025, then decreased by 6.9% to $27.0 million in 2026.
  • Business Quant data shows Research & Development for CLX at $27.0 million in Q1 2026, $29.0 million in Q4 2025, and $28.0 million in Q3 2025.